Oral treatment of hemophilia

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069100, C435S320100, C435S325000, C435S455000, C800S004000, C800S007000, C800S008000, C800S014000, C800S017000

Reexamination Certificate

active

10485696

ABSTRACT:
Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a subject a therapeutically effective amount of the deficient antigen, wherein the antigen is not present in a liposome. In one embodiment, the method increases hemostasis in a subject having hemophilia A or B, by orally administering to the hemophiliac a therapeutically effective amount of the appropriate clotting factor other than in a liposome, sufficient to induce oral tolerance and supply exogenous clotting factor to the subject.

REFERENCES:
patent: 4348384 (1982-09-01), Horikoshi et al.
patent: 4873316 (1989-10-01), Meade et al.
patent: 5589604 (1996-12-01), Drohan et al.
patent: 5880327 (1999-03-01), Lubdon et al.
patent: 5948407 (1999-09-01), McGuinness et al.
patent: 6046380 (2000-04-01), Clark
patent: 6221349 (2001-04-01), Couto et al.
patent: 6255554 (2001-07-01), Lubon et al.
patent: 6344596 (2002-02-01), Velander et al.
patent: 0 294 910 (1988-12-01), None
patent: WO 80/01456 (1980-07-01), None
patent: WO 95/27512 (1995-10-01), None
Terada et al, Vox Sang. 80(1):61-62, 2001.
Pasi et al, Lancet. 361(9371):1801-9, 2003.
Clark et al,. “The Molecular Manipulation of Milk Composition,”Genome 31:950-955 (1989).
Hemker et al., “Oral Treatment of Hæmophilia A by Gastrointestinal Absorption of Factor VIII Entrapped in Liposomes,”The Lancet, pp. 70-71, Jan. 12, 1980.
Hennighausen, “Transgenic Factor VIII: The Milky Way and Beyond,”Nature Biotechnol. 15:945-946 (1997).
High, “Gene-Based Approaches to the Treatment of Hemophilia,”Ann. N.Y. Acad. Sci. 961:63-64 (2002).
Kaplan et al., “Factor VIII Inhibitors. Potential for Prevention of Inhibitor Formation by Immune Tolerance,”Semin Thromb Hemost. 26:173-178 (2000).
Kay et al., “Gene Therapy for the Hemophilias,”Proc. Natl. Acad. Sci. USA 96:9973-9975 (1999).
Lindgren et al., “Does Peroral Administration of Factor VIII Induce Oral Tolerance in Patients with Acquired Haemophilia A?,”Throm Haemost 83:632-633 (2000).
Mariani et al., “Immune Tolerance to Factor VIII: The International Registry Data,”Adv. Exp. Med. Biol. 386:201-208 (1995).
Morcöl et al., “The Porcine Mammary Gland as a Bioreactor for Complex Proteins,”Ann. N.Y. Acad. Sci.2:218-233 (1994).
Niemann et al., “Expression of Human Blood Clotting Factor VIII in the Mammary Gland of Transgenic Sheep,”Transgenic Res. 8:237-247 (1999).
Paleyanda et al. “Transgenic Pigs Produce Functional Human Factor VIII in Milk,”Nature Biotechnol. 15:971-975 (1997).
Roberts, “Induction of Immune Tolerance to Factor VIII: A Plea for Caution,”JAMA 259:84-85 (1988).
Udall et al., “Development of Gastrointestinal Mucosal Barrier. I. The Effect of Age on Intestinal Permeability to Macromolecules,”Pediatr. Res. 15:241-244 (1981).
Velander et al., “Transgenic Livestock as Drug Factories,”Sci Am. 276:70-74 (1997).
Warshaw et al., “Intestinal Absorption of Intake Antigenic Protein,”Surgery 76:495-499 (1974).
Wilmut et al., “Modification of Milk Composition,”J. Reprod. Fert. Suppl. 41:135-146 (1990).
Yee et al., “Oral Immune Tolerance Induction to Factor VIII Via Breast Milk, a Possibility?,”Haemophilia 6:591 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Oral treatment of hemophilia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral treatment of hemophilia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral treatment of hemophilia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3770879

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.